Trial Profile
Clinical Trials Insight: 700023976
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 04 Mar 2008
Price :
$35
*
At a glance
- Drugs Alvespimycin (Primary) ; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Kosan Biosciences
- 28 Feb 2008 Kosan has reported that this trial will not be continued.
- 20 Jun 2007 New trial record.